Related Experiment Video

Updated: Jun 6, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

The need for personalised medicine for rheumatoid arthritis

John D Isaacs1, Gianfranco Ferraccioli

  • 1Institute of Cellular Medicine, Musculoskeletal Research Group, Newcastle University, Newcastle, UK. j.d.isaacs@ncl.ac.uk

Annals of the Rheumatic Diseases
|November 12, 2010
PubMed

Insights

Predicting rheumatoid arthritis treatment response is crucial for personalized medicine. Identifying biomarkers for biological therapies will optimize efficacy and minimize adverse effects, improving patient outcomes and reducing costs.

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacogenomics

Background:

  • Biological therapies offer expanding treatment options for rheumatoid arthritis (RA).
  • Significant patient variability exists in the efficacy and adverse effects of these RA treatments.
  • Optimizing the benefit:risk ratio of biologicals is essential to prevent joint damage.

Purpose of the Study:

  • To summarize the current state of personalized medicine in rheumatoid arthritis treatment.
  • To highlight the need for predictors of response and adverse effects for biological therapies.
  • To discuss the potential of personalized medicine in matching patients with optimal RA treatments.

Main Methods:

  • Review of current licensed biological therapies for rheumatoid arthritis.
  • Analysis of existing clinical trial and real-world data on treatment efficacy and heterogeneity.
  • Discussion of the challenges and future directions in biomarker discovery for RA treatments.

Main Results:

  • Noteworthy discoveries in predicting treatment response have been made.
  • Significant interpatient heterogeneity in response and adverse effects necessitates personalized approaches.
  • The potential for reduced treatment costs through optimized patient-treatment matching is recognized.

Conclusions:

  • Further research is needed to confirm and validate existing biomarkers for RA biologicals.
  • Large-scale, international collaborations are required to identify robust predictive biomarkers.
  • Personalized medicine holds promise for optimizing rheumatoid arthritis treatment and improving patient outcomes.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...